Palantir thread

gld998

High Supremacy Member
Joined
Feb 21, 2008
Messages
38,046
Reaction score
2,091
knn.. still strong.. now got abit of money to buy a few hundred units up price..knn
 

mooseolly

High Supremacy Member
Joined
Mar 21, 2009
Messages
31,481
Reaction score
14,613
This stock I have been buying. Always go up down up down within the 21-24 range siah like CCIV.
 

gld998

High Supremacy Member
Joined
Feb 21, 2008
Messages
38,046
Reaction score
2,091
This stock I have been buying. Always go up down up down within the 21-24 range siah like CCIV.
I got trick by a fake outbreak bought some at 25 and ppl receiving steamy cheques. Now trying to average down if drops below 22
 

eyz

Arch-Supremacy Member
Joined
Jul 10, 2002
Messages
12,050
Reaction score
2,104
I sold a put last night at 21, expiring in 1 month time.
 

gld998

High Supremacy Member
Joined
Feb 21, 2008
Messages
38,046
Reaction score
2,091
someone is queing big volumes at 22.89.. buy a bit at 22.90..
 

gld998

High Supremacy Member
Joined
Feb 21, 2008
Messages
38,046
Reaction score
2,091
Investors will be keeping an eye on Palantir Technologies (NYSE:PLTR) stock today after ARK Invest’ Cathie Wood doubled down on the software maker.

A banner for Palantir (PLTR) hangs on the New York Stock Exchange.

Source: rblfmr / Shutterstock.com
Wood’s ARK Innovation ETF (NYSEARCA:ARKK) reportedly bought 1,514,080 shares of Palantir, worth about $33 million at yesterday’s closing price. According to the fund’s filing dated today, it now holds 16,190,220 shares valued at $350.4 million. PLTR stock is the exchange-trade fund’s 19th-biggest holding.

The ETF’s purchase comes as Palantir took a big step in expanding its footprint in the private and public health sectors. The company announced the hiring of Dr. William J. Kassler, MD, MPH, as its first U.S. Government Chief Medical Officer, from International Business Machine’s (NYSE:IBM)Watson Health unit.

PLTR has grown its healthcare business, and in recent months, made key senior hires with deep domain expertise in life sciences, pharmaceuticals and public health. Palantir also announced a multi-year strategic partnership with Celularity, a clinical-stage biotech firm. No financial details of that tie-in were disclosed.


https://investorplace.com/2021/05/pltr-stock-3-big-reasons-why-palantir-is-climbing-again-today/
 
Important Forum Advisory Note
This forum is moderated by volunteer moderators who will react only to members' feedback on posts. Moderators are not employees or representatives of HWZ Forums. Forum members and moderators are responsible for their own posts. Please refer to our Community Guidelines and Standards and Terms and Conditions for more information.
Top